Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Enhancing Chemotherapy Response With Bmi-1 Silencing in Ovarian Cancer

PLoS ONE
Multidisciplinary
2011English

Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation

Cancer Research
Cancer ResearchOncology
2011English

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

PLoS ONE
Multidisciplinary
2009English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

KIF15 Facilitates Gastric Cancer via Enhancing Proliferation, Inhibiting Apoptosis, and Predict Poor Prognosis

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2015English

Targeting the Dopamine 1 Receptor or Its Downstream Signalling by Inhibiting Phosphodiesterase-1 Improves Cognitive Performance

British Journal of Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy